These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7869779)

  • 21. The cost effectiveness of varenicline for smoking cessation.
    Halpern MT; Dirani R; Schmier JK
    Manag Care Interface; 2007 Oct; 20(10):18-25. PubMed ID: 18405203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow.
    Boyd KA; Briggs AH
    Addiction; 2009 Feb; 104(2):317-25. PubMed ID: 19149829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden.
    Bolin K; Lindgren B; Willers S
    Chest; 2006 Mar; 129(3):651-60. PubMed ID: 16537864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Free nicotine patch giveaway program 12-month follow-up of participants.
    Cummings KM; Hyland A; Fix B; Bauer U; Celestino P; Carlin-Menter S; Miller N; Frieden TR
    Am J Prev Med; 2006 Aug; 31(2):181-4. PubMed ID: 16829336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smoking cessation in primary care: a clinical effectiveness trial of two simple interventions.
    Milch CE; Edmunson JM; Beshansky JR; Griffith JL; Selker HP
    Prev Med; 2004 Mar; 38(3):284-94. PubMed ID: 14766110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Methods and cost effectiveness of nicotine abstinence].
    Górecka D
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():79-82. PubMed ID: 15524024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Women's reports of smoking cessation advice during reproductive health visits and subsequent smoking cessation.
    Pollak KI; McBride CM; Scholes D; Grothaus LC; Civic D; Curry SJ
    Am J Manag Care; 2002 Oct; 8(10):837-44. PubMed ID: 12395952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of the Danish smoking cessation interventions: subgroup analysis based on the Danish Smoking Cessation Database.
    Olsen KR; Bilde L; Juhl HH; Kjaer NT; Mosbech H; Evald T; Rasmussen M; Hiladakis H
    Eur J Health Econ; 2006 Dec; 7(4):255-64. PubMed ID: 16816946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. National trends in the provision of smoking cessation aids within the Veterans Health Administration.
    Jonk YC; Sherman SE; Fu SS; Hamlett-Berry KW; Geraci MC; Joseph AM
    Am J Manag Care; 2005 Feb; 11(2):77-85. PubMed ID: 15726855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cost effectiveness of pharmacotherapies for smoking cessation: necessary but not sufficient?
    Shanahan M; Doran C; Gates J; Shakeshaft A; Mattick RP
    Appl Health Econ Health Policy; 2003; 2(2):76-8. PubMed ID: 14619277
    [No Abstract]   [Full Text] [Related]  

  • 31. Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness.
    Stapleton JA; Lowin A; Russell MA
    Lancet; 1999 Jul; 354(9174):210-5. PubMed ID: 10421303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Economic evaluation of pharmacotherapies for smoking cessation].
    Antoñanzas F; Portillo F
    Gac Sanit; 2003; 17(5):393-403. PubMed ID: 14599422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling.
    Fiscella K; Franks P
    JAMA; 1996 Apr; 275(16):1247-51. PubMed ID: 8601956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cost-benefit analysis of smoking cessation programs during the first trimester of pregnancy for the prevention of low birthweight.
    Hueston WJ; Mainous AG; Farrell JB
    J Fam Pract; 1994 Oct; 39(4):353-7. PubMed ID: 7931114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Public health focus: effectiveness of smoking-control strategies--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Sep; 41(35):645-7, 653. PubMed ID: 1508130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services.
    Bauld L; Boyd KA; Briggs AH; Chesterman J; Ferguson J; Judge K; Hiscock R
    Nicotine Tob Res; 2011 Feb; 13(2):135-45. PubMed ID: 21196451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of an intensive telephone-based intervention for smoking cessation.
    Smith MW; An LC; Fu SS; Nelson DB; Joseph AM
    J Telemed Telecare; 2011; 17(8):437-40. PubMed ID: 22025745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allocation of resources between smoking cessation methods and lovastatin treatment of hypercholesterolaemia: based on cost effectiveness and the social welfare function.
    Plans-Rubió P
    Pharmacoeconomics; 2004; 22(1):55-69. PubMed ID: 14720082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of a health professional training program for treatment of tobacco addiction.
    Olano-Espinosa E; Matilla-Pardo B; Minué C; Antón E; Gómez-Gascón T; Ayesta FJ
    Nicotine Tob Res; 2013 Oct; 15(10):1682-9. PubMed ID: 23547275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists.
    Cantor SB; Deshmukh AA; Luca NS; Nogueras-González GM; Rajan T; Prokhorov AV
    Addict Behav; 2015 Jun; 45():79-86. PubMed ID: 25644592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.